Idiopathic and radiation-induced ocular telangiectasia: The involvement of the ATM gene

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 8, 2003, Pages 3257-3262

  Mauget Faÿsse, Martine ^a   Vuillaume, Michèle ^b   Quaranta, Maddalena ^a   Moullan, Norman ^b   Angèle, Sandra ^b   Friesen, Marlin D ^c   Hall, Janet ^b,c  

^a Rabelais Ophthalmologic Center   (France)

^b DNA Repair Group   (France)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; COMPLEMENTARY DNA; ENDONUCLEASE;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; ATAXIA TELANGIECTASIA; ATM GENE; CELL LINE; CHOROID; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OCULAR TELANGIECTASIA; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; RETINA; RETINA MACULA AGE RELATED DEGENERATION;

ADULT; AGED; AGED, 80 AND OVER; ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CELL LINE; CHOROID DISEASES; DNA FINGERPRINTING; DNA PRIMERS; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FEMALE; HETEROZYGOTE; HUMANS; MACULAR DEGENERATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; MUTATION, MISSENSE; PILOT PROJECTS; PROTEIN-SERINE-THREONINE KINASES; RADIATION INJURIES; RETINA; RETINAL DISEASES; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0042844840     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-1269     Document Type: Article

References (43)

1. Sedgwick RP, Boder E. Ataxia-telangiectasia. In: De Jong JMBV, ed. Hereditary Neuropathies and Spinocerebellar Atrophies: Handbook of Clinical Neurology. Amsterdam/New York: Elsevier Science Publishers BV; 1991:347-423.
2. Swift M, Morrell D, Cromartie E, et al. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet. 1986;39:573-583.
3. Woods CG, Bundey SE, Taylor AM. Unusual features in the inheritance of ataxia telangiectasia. Hum Genet. 1990;84:555-562.
4. Swift M, Reitnauer PJ, Morrell D, et al. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med. 1987;316:1289-1294.
5. Angèle S, Hall J. The ATM gene and breast cancer: is it really a risk factor? Mutat Res. 2000;462:167-178.
6. Savitsky K, Bar-Shira A, Gilard S, et al. A single ataxia-telangiectasia gene with a product similar to PI 3-kinase. Science. 1995;268:1749-1753.
7. Shiloh Y, Kastan MB. ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res. 2001;83:209-254.
8. Khanna KK, Lavin MF, Jackson SP, et al. ATM, a central controller of cellular responses to DNA damage. Cell Death Diff. 2001;8:1052-1065.
9. Stankovic T, Kidd AMJ, Sutcliffe A, et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet. 1998;62:334-345.
10. McConville CM, Stankovic T, Byrd PJ, et al. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 1996;59:320-330.
11. Gatti RA, Tward A, Concannon P. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab. 1999;68:419-422.
12. Barlow C, Eckhaus MA, Schäffer AA, Wynshaw-Boris A. Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat Genet., 1999;21:359-360.
13. Chenevix-Trench G, Spurdle AB, Gatei M, et al. Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002;94:205-215.
14. Mauget-Faÿsse M, Coquard R, Français-Maury C, et al. Radiotherapy for age-related macular degeneration: risk factors, prevention and treatment of side-effects. J Fr Ophtalmol. 2000;23:127-136.
15. Mauget-Faÿsse M, Chiquet C, Milea D, et al. Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol. 1999;83:923-928.
16. Liu Q, Somer SS. Restriction endonuclease fingerprinting (REF): A sensitive method for screening mutations in long, contiguous segments of DNA. Biotechniques. 1995;18:470-477.
17. Gilad S, Khosravi R, Harnik R, et al. Identification of ATM mutations using extended RT-PCR and restriction endonuclease fingerprinting, and elucidation of the repertoire of A-T mutations in Israel. Hum Mutat. 1998;11:69-75.
18. Sandoval N, Platzer M, Rosenthal A, et al. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet. 1999;8:69-79.
19. Laken S, Jackson PE, Kinzler KW, et al. Genotyping by mass spectrometric analysis of short DNA fragments. Nat Biotech. 1998; 16:1352-1356.
20. Maillet P, Vaudan G, Chappuis P, et al. PCR-mediated detection of a polymorphism in the ATM gene. Mol Cell Probes. 1999;13:67-69.
21. Gilad S, Khosravi R, Shkedy D, et al. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet. 1996;5:433-439.
22. Menchini U, Virgili G, Bandello F, et al. Bilateral juxtafoveolar telangiectasis in monozygotic twins. Am J Ophthalmol. 2000;129:401-403.
23. Issacs TW, McAllister IL. Familial idiopathic juxtafoveolar retinal telangiectasis. Eye. 1996;10:639-642.
24. Leys A, Gilbert HD, Van De Sompel W, et al. Familial spastic paraplegia and maculopathy with juxtafoveolar retinal telangiectasis and subretinal neovascularization. Retina. 2000;20:184-189.
25. Chew EY, Murphy RP, Newsome DA, et al. Parafoveal telangiectasis and diabetic retinopathy. Arch Ophthalmol. 1986;104:71-75.
26. Millay RH, Klein ML, Handelman IL, et al. Abnormal glucose metabolism and parafoveal telangiectasia. Am J Ophthalmol. 1986; 102:363-370.
27. Maberley DA, Yannuzzi LA, Gitter K, et al. Radiation exposure: a new risk factor for idiopathic perifoveal telangiectasis. Ophthalmology. 1999;106:2248-2252; discussion 2252-2253.
28. Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990;10:1-8.
29. Spaide RF, Yannuzzi LA, Sklater JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina. 1995;15:100-110.
30. Uyama M, Mitsumasa W, Yoshimi N, et al. Apolypoidal choroidal vasculopathy: natural history. Am J Ophthalmol. 2002;133:639-648.
31. Lip PL, Hope-Ross MW, Gibson JM. Idiopathic polypoidal choroidal vasculopathy: a disease with diverse clinical spectrum and systemic associations. Eye. 2000;14:695-700.
32. Terasaki H, Miyake Y, Suzuki T, et al. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol. 2002;86:321-327.
33. Spaide RF, Leys A, Hermann-Delemazure B, et al. Radiation-associated choroidal neovasculopathy. Ophthalmology. 1999;106:2254-2260.
34. Archer DB, Gardiner TA. Ionizing Radiation and the retina. Curr Opin Ophthalmol. 1994;5:59-65.
35. Maillet P, Chappuis PO, Vaudan G, et al. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer. 2000;88:928-931.
36. Hall EJ, Schiff PB, Hanks GE, et al. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am. 1998;4:385-389.
37. Larson GP, Zhang G, Ding S, et al. An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genet Test. 1997-98;1:165-170.
38. Spurdle AB, Hopper JL, Chen X, et al. No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res. [serial online]. 2002;4:R15.
39. Dork T, Bendix R, Bremer M, et al. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. [serial online]. 2001;61:7608-7615.
40. Laake K, Jansen L, Hahnemann JM, et al. Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia. Hum Mutat. 2000;16:232-246.
41. Grønbæk K, Worm J, Ralfkiaer E, et al. ATM mutations are associated with inactivation of the ARF-TP53 tumour suppresser in diffuse large B-cell lymphoma. Blood. 2002;100:1430-1437.
42. Rotman G, Shiloh Y. ATM: from gene to function. Hum Mol Genet. 1998;7:1555-1563.
43. Yang DQ, Kastan MB. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol. 2000;2:893-898.